Logo

Johnson & Johnson

JNJ

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX… read more

Healthcare

Drug Manufacturers - General

80 years

USD

85

/100

Price

per share adjusted in USD

$170.85

Price

+0.07%

$0.11

Market Cap

$411.465b

Large

Price/Earnings

18.3x

17.5x

3y Avg

19.6x

5y Avg

Financials Overview

Key metrics over the past few years

+27.3%

EBITDA Margin

+23.3%

Net Profit Margin

+10.5%

Free Cash Flow Margin
Revenue

$90.627b

+2.0%

1y CAGR

+4.3%

3y CAGR

+3.6%

5y CAGR
Earnings

$22.661b

+61.1%

1y CAGR

+32.4%

3y CAGR

+20.7%

5y CAGR
EPS

$9.35

+61.5%

1y CAGR

+35.9%

3y CAGR

+23.4%

5y CAGR
Book Value

$78.473b

$193.389b

Assets

$114.916b

Liabilities

$50.761b

Debt
Debt to Assets

26.3%

1.5x

Debt to EBITDA
Free Cash Flow

$16.397b

-17.4%

1y CAGR

-0.8%

3y CAGR

-3.9%

5y CAGR

Financial Reports

Earnings and other important metrics. Amounts in USD.
No items found.
Press Releases
Statements and updates from the company
↑ TopSummaryPriceFinancialsPress Releases